Ultraxime
Formulation
After reconstitution, each 5 mL (1 teaspoonful) suspension contains:
Cefixime 100 mg

 

After reconstitution, each mL suspension (oral drops) contains:
Cefixime 20 mg

 

Cefixime

Ultraxime®

Prescription Drug

Indication

For the treatment of the following infections due to susceptible microorganisms:

  • Acute bronchitis, acute exacerbations of chronic bronchitis, bronchiectasis with infection, secondary infections in chronic respiratory tract diseases, pneumonia
  • Urinary tract infections including pyelonephritis, cystitis and cystourethritis
  • Uncomplicated gonorrhea (cervical/urethral)
  • Cholecystitis, cholangitis
  • Scarlet fever
  • Sinusitis, tonsillitis, pharyngitis, otitis media
  • Typhoid fever (enteric fever) including multi-drug resistant typhoid fever

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.